Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000085556 | SCV002241291 | pathogenic | not provided | 2024-05-23 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 21 of the ABCA4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is present in population databases (rs61752415, gnomAD 0.0009%). Disruption of this splice site has been observed in individual(s) with generalized retinal dystrophy and/or Stargardt disease (PMID: 22229821, 28559085). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99205). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV004815101 | SCV005069683 | pathogenic | Retinal dystrophy | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000085556 | SCV000117693 | not provided | not provided | no assertion provided | not provided |